Enhancement of therapeutic efficacy of Brinzolamide for Glaucoma by nanocrystallization and tyloxapol addition.

Shuya MasudaShiho YanoTomohisa TadokoroHiroko OtakeNoriaki Nagai

Published in: Journal of pharmaceutical health care and sciences (2024)

The combination of BRI nanocrystallization and tyloxapol is expected to be highly effective in glaucoma treatment and a useful tool for new ophthalmic drug delivery.

Keyphrases

drug delivery
optic nerve
cancer therapy
cataract surgery
replacement therapy